Looking forwards

Forrest thinks that a 10c dividend for the next financial year is entirely reasonable, and I would agree. This time last year long suffering shareholders were still waiting for the CDC to publish their updated guidelines and still waiting for Japan to implement QFT-GIT.

The Japan release was delayed until January 2010 and the US CDC did not publish the guidelines until June 2010, one year later. Despite these setbacks sales increased by 34%, well within the forecast target.

For the first time ever Cellestis are not having to look forward to an approval to be granted or a guideline to be published before sales can be energetically pursued; the way forwards is clear.